In recent decades, a wealth of research and the development of highly effective therapies have led to markedly improved outcomes for patients with multiple myeloma, but these benefits have not been ...
Health Equity has become a key priority for healthcare organizations, validated in the Becker’s/TruLite 2022 Benchmark Survey, and they are increasingly aware of the repercussions of inequities on ...
This issue of Evidence-Based Oncology includes a special report, cowritten with our contributor Ryan Flinn, that started with questions at the 2024 American Society of Clinical Oncology (ASCO) Annual ...
High levels of competition have propped up acquisition multiples, which remain above 10x EV-to-EBITDA Strong private equity fundraising drives dry powder higher. Much of the recent fundraising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback